From Step Therapy and Prior Authorization to the harmful impacts of misguided policies such as the Inflation Reduction Act, Most-favored Nation type drug pricing proposals, and the 340B program, patients are increasingly facing barriers accessing the treatments they need. Come join an amazing line-up of patient advocacy leaders to hear about the latest data and […]
Metabolic Dysfunction-Associated Steatotic Liver Disease | MASLD 2026 September 14-15, 2026 | Online Join our 2-days virtual MASLD conference featuring global experts and cutting-edge, content-rich research presentations. Welcome again to the MASLD Virtual Conference! We’re honored to host this global gathering of experts and researchers. In this 2-days program, you’ll explore cutting-edge insights into Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)—a […]
MASLD/NAFLD & Metabolic Liver Disease MASLD/NAFLD & Metabolic Liver Disease encompasses a spectrum of liver disorders driven primarily by metabolic dysfunction, including obesity, insulin resistance, type 2 diabetes mellitus, dyslipidemia, and sedentary lifestyle. Metabolic dysfunction–associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), is now the most common chronic liver condition globally […]
The Advanced Advocacy Academy (A3) was created to close a critical gap in the liver community: patients and caregivers needed the skills, knowledge, and confidence to advocate effectively—and to help drive meaningful change in healthcare. A3 equips advocates with practical training in communication, policy engagement, and strategic storytelling so they can influence decisions that impact […]
Join us for the 21st Annual Cardiometabolic Health Congress (CMHC), building on over two decades of leadership in cardiometabolic health education. From October 15-17, 2026, with a pre-conference on October […]
